Canadian Guidelines for Treatment of Erysipelas
For erysipelas, treat with penicillin (500 mg QID) or amoxicillin (500 mg TID) for 5-10 days as first-line therapy, based on the streptococcal etiology of this infection.
Important Clarification: No Canada-Specific Guidelines Provided
The evidence provided does not contain Canadian-specific guidelines for erysipelas. However, the IDSA (Infectious Diseases Society of America) 2014 guidelines are widely adopted in North America, including Canada, and provide the framework for treatment 1.
First-Line Treatment
Beta-lactam antibiotics targeting beta-hemolytic streptococci (primarily Group A Streptococcus) are the cornerstone of therapy:
- Penicillin V: 500 mg orally four times daily for 5-10 days
- Amoxicillin: 500 mg orally three times daily for 5-10 days
These narrow-spectrum agents are preferred because erysipelas is caused by streptococci, and adherence to guideline-directed therapy (using amoxicillin, amoxicillin/clavulanic acid, clindamycin, or pristinamycin) is associated with significantly better outcomes 2.
Route of Administration
Oral therapy is as effective as intravenous therapy for most cases. Research demonstrates that oral macrolides were more effective than IV penicillin (RR 0.85,95% CI 0.73-0.98), supporting the use of oral antibiotics in outpatient settings 3.
For severe cases requiring parenteral therapy, benzyl penicillin via continuous infusion pumps is highly effective and safe, increasing penicillin use by 36 percentage points and achieving approximately 20 percentage points higher cure rates 4.
Alternative Regimens for Penicillin Allergy
- Macrolides (e.g., azithromycin, erythromycin)
- Clindamycin
- First-generation cephalosporins (if no severe penicillin allergy)
Note that macrolides/streptogramins showed superior efficacy compared to penicillin antibiotics (RR 0.84,95% CI 0.73-0.97) 3.
Critical Distinction: Erysipelas vs. Cellulitis
Do not confuse erysipelas with limited cellulitis, as they require different antibiotic coverage:
- Erysipelas: Caused by streptococci → treat with penicillin
- Limited cellulitis: Often caused by S. aureus → requires broader spectrum coverage
Laboratory markers help differentiate:
- CRP ≥3.27 mg/dL suggests erysipelas (75% sensitivity, 73.2% specificity) 5
- Higher leukocyte counts also favor erysipelas 5
- Erysipelas shows prompt response to penicillin within 24-48 hours
Common Pitfalls to Avoid
Overuse of broad-spectrum antibiotics: Erysipelas responds to narrow-spectrum penicillin; using broader agents unnecessarily increases antimicrobial resistance risk 4
Failure to monitor for progression: Even with appropriate antibiotics, invasive Group A Streptococcal disease can progress to complications like epiglottitis or toxic shock syndrome 6. Monitor closely for:
- Worsening systemic symptoms
- Respiratory compromise
- Signs of deeper tissue involvement
Inadequate treatment of recurrent erysipelas: Address predisposing factors including venous insufficiency, lymphedema, and skin barrier disruption 7
Duration of Therapy
5-10 days is the recommended duration 1. The evidence base for optimal duration is limited, but most guidelines suggest 7-10 days for complete resolution.
Severe or Complicated Cases
For patients with:
- Systemic toxicity
- Immunocompromise
- Failed outpatient therapy
- Concern for necrotizing infection
Consider intravenous penicillin G or ampicillin plus clindamycin (clindamycin added for toxin suppression in severe streptococcal infections) 6.